Next Article in Journal
Coronavirus Genomics and Bioinformatics Analysis
Next Article in Special Issue
Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
Previous Article in Journal
Antiviral Strategies for Pandemic and Seasonal Influenza
Previous Article in Special Issue
Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel
Viruses 2010, 2(8), 1782-1803; doi:10.3390/v2081782

Last Stop Before Exit – Hepatitis C Assembly and Release as Antiviral Drug Targets

1,* , 1,2
1 Hepatitis C Laboratory, Center of Infection and Immunity of Lille, University Lille Nord de France, CNRS UMR8204, INSERM U1019, Pasteur Institute of Lille, 1, rue du professeur Calmette, BP447, 59021 Lille, France 2 Institute of Biochemistry of the Romanian Academy, Splaiul Independentei 296, 060031, Bucharest, Romania
* Author to whom correspondence should be addressed.
Received: 15 June 2010 / Revised: 16 July 2010 / Accepted: 4 August 2010 / Published: 24 August 2010
(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
View Full-Text   |   Download PDF [3519 KB, uploaded 12 May 2015]   |  


Chronic Hepatitis C infection is a global health problem. While primary infection is often inapparent, it becomes chronic in most cases. Chronic infection with Hepatitis C virus (HCV) frequently leads to liver cirrhosis or liver cancer. Consequently, HCV infection is one of the leading causes for liver transplantation in industrialized countries. Current treatment is not HCV specific and is only effective in about half of the infected patients. This situation underlines the need for new antivirals against HCV. To develop new and more efficient drugs, it is essential to specifically target the different steps of the viral life cycle. Of those steps, the targeting of HCV assembly has the potential to abolish virus production. This review summarizes the advances in our understanding of HCV particle assembly and the identification of new antiviral targets of potential interest in this late step of the HCV life cycle.
Keywords: Hepatitis C; assembly; release; antivirals Hepatitis C; assembly; release; antivirals
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Tews, B.A.; Popescu, C.-I.; Dubuisson, J. Last Stop Before Exit – Hepatitis C Assembly and Release as Antiviral Drug Targets. Viruses 2010, 2, 1782-1803.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert